Vexim expanded its SpineJack® patent portfolio in Asia with the issuance of new patents in Japan and China. Further, the company is initiating biological and mechanical qualifying tests required to register its products by the China FDA.

Contact Us

  • This field is for validation purposes and should be left unchanged.

0